ID

12133

Descripción

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072

Palabras clave

Versiones (3)
  1. 30/9/15 30/9/15 -
  2. 27/10/15 27/10/15 -
  3. 3/11/15 3/11/15 - Julian Varghese
Subido en

30 de septiembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

CLL History NCT00090051 BO17072

Inglés

History of Chronic lymphocytic leukemia NCT0090051

1 formularios  
History of CLL
Descripción

History of CLL

Date of first diagnosis
Descripción

Date of first diagnosis

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI-1
C0011008
dd/mm/yy
Is Binet stage at diagnosis knowns?
Descripción

Binet stage

Tipo de datos

integer

Binet stage at diagnosis
Descripción

Binet stage at diagnosis

Tipo de datos

integer

Date of last progression
Descripción

Date of last progression

Tipo de datos

date

Unidades de medida
  • dd/mm/yy
Alias
UMLS CUI-1
C0011008
dd/mm/yy
Site of progression (tick all that apply)
Descripción

Site of progression (tick all that apply)

Tipo de datos

integer

Other progression
Descripción

Other progression

Tipo de datos

text

Binet stage at screening
Descripción

Binet stage at screening

Stage at screening
Descripción

Stage at screening

Tipo de datos

integer

Previous chemotherapy
Descripción

Previous chemotherapy

Alias
UMLS CUI-1
C0205156
UMLS CUI-2
C0392920
Type of previous chemotherapy
Descripción

Type of previous chemotherapy

Tipo de datos

integer

Previous chemotherapy
Descripción

Previous chemotherapy

Amendment C onwards
Descripción

Amendment C onwards

Tipo de datos

integer

Volver a la parte superior de la página

Similar models

History of Chronic lymphocytic leukemia NCT0090051

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
History of CLL
Date
Item
Date of first diagnosis
date
C0011008 (UMLS CUI-1)
Item
Is Binet stage at diagnosis knowns?
integer
Binet stage
Code List
Is Binet stage at diagnosis knowns?
CL Item
yes (-> specify below) (1)
CL Item
no (2)
Item
Binet stage at diagnosis
integer
Binet stage
Code List
Binet stage at diagnosis
CL Item
A (1)
C2698392 (UMLS CUI-1)
CL Item
B (2)
C2698393 (UMLS CUI-1)
CL Item
C (3)
C2698394 (UMLS CUI-1)
Date of last progression
Item
Date of last progression
date
C0011008 (UMLS CUI-1)
Item
Site of progression (tick all that apply)
integer
Site of progression
Code List
Site of progression (tick all that apply)
CL Item
peripheral blood (1)
C0229664 (UMLS CUI-1)
CL Item
lymph nodes (2)
C0024204 (UMLS CUI-1)
CL Item
bone marrow (3)
C0005953 (UMLS CUI-1)
CL Item
other (-> specify below) (4)
Site of progression
Item
Other progression
text
Item Group
Binet stage at screening
Item
Stage at screening
integer
Binet stage
Code List
Stage at screening
CL Item
A (1)
C2698392 (UMLS CUI-1)
CL Item
B (2)
C2698393 (UMLS CUI-1)
CL Item
C (3)
C2698394 (UMLS CUI-1)
Item Group
Previous chemotherapy
C0205156 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
Item
Type of previous chemotherapy
integer
Type of previous chemotherapy
Code List
Type of previous chemotherapy
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
Item Group
Previous chemotherapy
Item
Amendment C onwards
integer
Type of previous chemotherapy
Code List
Amendment C onwards
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial